StockData
RANINasdaqPharmaceutical PreparationsFiscal year ends December 31

Rani Therapeutics Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.65+0.01 (+1.51%)

Close on Oct 19, 2026

Market cap
$121.72M
P/E (TTM)
–
Dividend yield
–

Rani Therapeutics Holdings, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Rani Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.